Cargando…

Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases

Brain metastases from gastrointestinal malignancies are exceedingly rare occurrences that carry a very poor prognosis. This holds especially true in cases where brain metastases from esophageal primaries are the initial presentation of a previously unidentified gastrointestinal malignancy. Our patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Grzywacz, Vincent, Balcueva, Ernie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731109/
https://www.ncbi.nlm.nih.gov/pubmed/29279695
http://dx.doi.org/10.1159/000481306
_version_ 1783286469389975552
author Grzywacz, Vincent
Balcueva, Ernie
author_facet Grzywacz, Vincent
Balcueva, Ernie
author_sort Grzywacz, Vincent
collection PubMed
description Brain metastases from gastrointestinal malignancies are exceedingly rare occurrences that carry a very poor prognosis. This holds especially true in cases where brain metastases from esophageal primaries are the initial presentation of a previously unidentified gastrointestinal malignancy. Our patient, a 60-year-old male with a past history of a right temporal teratoma, family history of breast cancer, and no smoking history, presented with a chief complaint of recurrent headaches. His history of present illness and physical examination included a two-month history of frontal headache, progressive fatigue, and unintentional weight loss. He underwent an extensive initial workup including CT-head, CT-abdomen/pelvis, CT-chest, bone scan, tumor marker analysis, and MRI-brain. The initial head CT revealed multiple intracranial lesions suspicious for malignancy. A PET scan later revealed his primary to be a malignancy of the distal esophagus. His treatment course thus far has been aggressive, consisting of surgical resection, systemic chemotherapy with capcetibine-oxaliplatin as well as paclitaxel-carboplatin, and radiation therapy. He has had several recurrences since starting treatment, but has continued to maintain a good performance status with only minor symptoms. Currently, the patient has survived for 17 months after his diagnosis of stage IV (T3, N2, M1) moderately differentiated adenocarcinoma and is undergoing treatment with trastuzumab and stereotactic radiosurgery. This report demonstrates that although cases of esophageal adenocarcinoma that present as brain metastases typically carry a poor prognosis, with early and aggressive treatment patients can survive well past one year after diagnosis.
format Online
Article
Text
id pubmed-5731109
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-57311092017-12-26 Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases Grzywacz, Vincent Balcueva, Ernie Case Rep Oncol Case Report Brain metastases from gastrointestinal malignancies are exceedingly rare occurrences that carry a very poor prognosis. This holds especially true in cases where brain metastases from esophageal primaries are the initial presentation of a previously unidentified gastrointestinal malignancy. Our patient, a 60-year-old male with a past history of a right temporal teratoma, family history of breast cancer, and no smoking history, presented with a chief complaint of recurrent headaches. His history of present illness and physical examination included a two-month history of frontal headache, progressive fatigue, and unintentional weight loss. He underwent an extensive initial workup including CT-head, CT-abdomen/pelvis, CT-chest, bone scan, tumor marker analysis, and MRI-brain. The initial head CT revealed multiple intracranial lesions suspicious for malignancy. A PET scan later revealed his primary to be a malignancy of the distal esophagus. His treatment course thus far has been aggressive, consisting of surgical resection, systemic chemotherapy with capcetibine-oxaliplatin as well as paclitaxel-carboplatin, and radiation therapy. He has had several recurrences since starting treatment, but has continued to maintain a good performance status with only minor symptoms. Currently, the patient has survived for 17 months after his diagnosis of stage IV (T3, N2, M1) moderately differentiated adenocarcinoma and is undergoing treatment with trastuzumab and stereotactic radiosurgery. This report demonstrates that although cases of esophageal adenocarcinoma that present as brain metastases typically carry a poor prognosis, with early and aggressive treatment patients can survive well past one year after diagnosis. S. Karger AG 2017-10-20 /pmc/articles/PMC5731109/ /pubmed/29279695 http://dx.doi.org/10.1159/000481306 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Grzywacz, Vincent
Balcueva, Ernie
Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases
title Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases
title_full Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases
title_fullStr Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases
title_full_unstemmed Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases
title_short Undiagnosed Esophageal Adenocarcinoma Presenting as Multiple Brain Metastases
title_sort undiagnosed esophageal adenocarcinoma presenting as multiple brain metastases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731109/
https://www.ncbi.nlm.nih.gov/pubmed/29279695
http://dx.doi.org/10.1159/000481306
work_keys_str_mv AT grzywaczvincent undiagnosedesophagealadenocarcinomapresentingasmultiplebrainmetastases
AT balcuevaernie undiagnosedesophagealadenocarcinomapresentingasmultiplebrainmetastases